How lenvatinib works against cancer
Lenvatinib , an oral multi-kinase inhibitor, has shown significant efficacy in the treatment of various malignant tumors such as thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. So,how does lenvatinib (lenvatinib) exert its anti-cancer effect?
It works by precisely inhibiting the activity of multiple receptor tyrosine kinases (RTKs), including vascular endothelial growth factor receptors (VEGFR

Lenvatinib does not only act on angiogenesis, it can also directly affect tumor cells. By inhibiting the activity of RTKs, such as FGFR and PDGFR, Lenvatinib can interfere with the proliferation signals of tumor cells, thereby slowing down or even preventing the growth of tumor cells.
Lenvatinib can also induce apoptosis in tumor cells by regulating signaling pathways related to apoptosis, such as the PI3K/AKT and MAPK pathways. This means that Lenvatinib can promote the self-destruction of tumor cells, thereby achieving the purpose of treatment.
The anti-cancer effects of Lenvatinib also include inhibiting the migration and invasion of tumor cells. This mechanism helps prevent the metastasis and spread of tumors and is of great significance in controlling the disease.
In summary,Lenvatinib (Lenvatinib) acts on tumor cells and the tumor microenvironment in a variety of ways, thereby achieving the treatment of various cancers. Its unique targeting and inhibitory effects on multiple signaling pathways make Lenvatinib an important drug in the current field of tumor treatment. However, any drug inevitably has side effects.Lenvatinib is no exception. During use, it is necessary to pay close attention to the patient's physical condition and make corresponding adjustments and management according to the actual situation.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)